WO2006032959A3 - Processes for the preparation of pyrrole derivatives - Google Patents
Processes for the preparation of pyrrole derivatives Download PDFInfo
- Publication number
- WO2006032959A3 WO2006032959A3 PCT/IB2005/002348 IB2005002348W WO2006032959A3 WO 2006032959 A3 WO2006032959 A3 WO 2006032959A3 IB 2005002348 W IB2005002348 W IB 2005002348W WO 2006032959 A3 WO2006032959 A3 WO 2006032959A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lower alkyl
- substituted
- bonded
- pharmaceutically acceptable
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59938304P | 2004-08-06 | 2004-08-06 | |
US59938204P | 2004-08-06 | 2004-08-06 | |
US60/599,382 | 2004-08-06 | ||
US60/599,383 | 2004-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006032959A2 WO2006032959A2 (en) | 2006-03-30 |
WO2006032959A3 true WO2006032959A3 (en) | 2007-02-22 |
Family
ID=35871147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/002348 WO2006032959A2 (en) | 2004-08-06 | 2005-08-05 | Processes for the preparation of pyrrole derivatives |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006032959A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ566286A (en) * | 2005-08-15 | 2010-06-25 | Arrow Int Ltd | Crystalline and amorphous sodium atorvastatin |
AU2006281237A1 (en) * | 2005-08-15 | 2007-02-22 | Arrow International Limited | Crystalline and amorphous sodium atorvastatin |
GB0613567D0 (en) * | 2006-07-07 | 2006-08-16 | Arrow Int Ltd | Crystalline sodium atorvastatin |
GB0613566D0 (en) * | 2006-07-07 | 2006-08-16 | Arrow Int Ltd | Crystalline sodium atorvastatin |
KR100850850B1 (en) | 2008-01-25 | 2008-08-06 | 주식회사종근당 | Method for the preparation of atorvastatin and intermediates used therein |
CN113105381A (en) * | 2021-04-08 | 2021-07-13 | 贵州大学 | Preparation method of biomass-based 2, 5-dimethyl-N-substituted pyrrole derivative |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
WO2001072706A1 (en) * | 2000-03-28 | 2001-10-04 | Biocon India Limited | Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
WO2003024959A1 (en) * | 2001-09-14 | 2003-03-27 | EGIS Gyógyszergyár Rt. | Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin |
WO2005118536A1 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Process for the preparation of atorvastatin |
-
2005
- 2005-08-05 WO PCT/IB2005/002348 patent/WO2006032959A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
WO2001072706A1 (en) * | 2000-03-28 | 2001-10-04 | Biocon India Limited | Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
WO2003024959A1 (en) * | 2001-09-14 | 2003-03-27 | EGIS Gyógyszergyár Rt. | Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin |
WO2005118536A1 (en) * | 2004-05-31 | 2005-12-15 | Ranbaxy Laboratories Limited | Process for the preparation of atorvastatin |
Non-Patent Citations (2)
Title |
---|
BAUMANN K L ET AL: "THE CONVERGENT SYNTHESIS OF CI-981 AN OPTICALLY ACTIVE HIGHLY POTENT TISSUE SELECTIVE INHIBITOR OF HMG-COA REDUCTASE", 1992, TETRAHEDRON LETTERS, VOL. 33, NR. 17, PAGE(S) 2283-2284, ISSN: 0040-4039, XP002397527 * |
WOO PETER W K ET AL: "Atorvastatin, an HMG-CoA reductase inhibitor and efficient lipid-regulating agent. Part I. Synthesis of ring-labeled (14C)atorvastatin", February 1999, JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, VOL. 42, NR. 2, PAGE(S) 121-127, ISSN: 0362-4803, XP002397528 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006032959A2 (en) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006032959A3 (en) | Processes for the preparation of pyrrole derivatives | |
WO2005095409A3 (en) | Tetrahydroquinoline derivatives and a process for preparing the same | |
NO20042584L (en) | Dibenzylamine Compounds and Pharmaceutical Use thereof | |
WO2003028728A8 (en) | 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands | |
WO2004014860A3 (en) | Fused heterocyclic compounds as peptidase inhibitors | |
WO2003045929A1 (en) | Bicyclic derivative, process for producing the same, and use | |
EP1724258A4 (en) | Heteroarylphenylurea derivative | |
WO2007060257A3 (en) | Diketopyrrolo-pyrrole compounds | |
EP1598349A4 (en) | Novel 2-pyridinecarboxamide derivatives | |
WO2003053366A3 (en) | Pyrimidine a2b selective antagonist compounds, their synthesis and use | |
CA2429642A1 (en) | Fused heteroaromatic glucokinase activators | |
EP1496052A4 (en) | Novel aminobenzamide derivative | |
TW200745034A (en) | New compounds | |
WO2008093674A1 (en) | Novel thiadiazole derivative having kinase inhibitory activity | |
WO2008126901A1 (en) | Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same | |
WO2008114812A1 (en) | Jak inhibitor | |
CA3191532A1 (en) | Compounds for suppressing egfr mutant cancer and pharmaceutical use thereof | |
WO2009041559A1 (en) | Indazole acrylic acid amide compound | |
Yuan et al. | New efficient synthesis of isoquinoline-1, 3 (2H, 4H)-diones and isoindolin-1-ones via sequential Ugi/cyclization reaction | |
CA2461060A1 (en) | Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof | |
MXPA05003695A (en) | New process for the synthesis of 1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid. | |
TW200604176A (en) | Process for producing bipyridinium compound | |
WO2004046151A3 (en) | Porphyrin derivatives | |
EP1908752A4 (en) | Novel 2-quinolone derivative | |
DK1340756T3 (en) | New beta-lactam compounds and processes for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |